Abstract:Kang-Xin Li, 1, &ast Hui Yuan, 1, &ast Jing Zhang, 2, 3 Xiao-bin Peng, 1 Wei-Fen Zhuang, 1 Wen-Tao Huang, 1 Hui-Xin Liang, 1 Ying Lin, 1 Ying-Zhen Huang, 1 Shu-Lan Qin 1 1 Department of Endocrinology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, People's Republic of China; 2 State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, 330004, People's Republic of China; 3 China Resources Jiangzhong Pharmaceutical Group Co., Ltd., Nanchang, Jiangxi, 330004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shu-Lan Qin, Email Introduction: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterised by insulin resistance, hyperglycaemia, and inflammation, with oxidative stress contributing to its progression. Curcumin (CUR), known for its anti-inflammatory, antioxidant, and insulin sensitising effects, has shown potential for the treatment of T2DM but is limited by low solubility and bioavailability. This study investigated long-circulating curcumin-loaded liposomes (CUR-LPs) to improve curcumin stability, solubility, and circulation and assessed their effect on insulin resistance in a murine model of T2DM. Methods: CUR-LPs were prepared using the ethanol injection method and characterized for morphology, particle size, zeta potential, encapsulation efficiency, drug-loading capacity, and in vitro release. Cell viability was tested on murine L929 cells. In a T2DM murine model, after four weeks of CUR-LP treatment, inflammatory markers TNF-α and IL-6 were measured by real-time polymerase chain reaction, and liver tissues were analyzed for glutathione (GSH) and superoxide dismutase (SOD) via colorimetry. Results: CUR-LPs were spherical, with an average diameter of (249 ± 2.3) nm and a zeta potential of (− 33.5 ± 0.8) mV. They exhibited an encapsulation efficiency of (99.2 ± 0.5) %and a drug-loading capacity of (1.63 ± 0.02) %. CUR embedding in liposomes significantly maintained CUR release. In L929 cells, over 80% viability was maintained at 12 uM CUR concentration after 24 h. In HFD/STZ-induced T2DM mice, CUR-LPs improved blood glucose and insulin levels more efficiently than free CUR, and CUR-LPs also reduced hepatic inflammation (TNF-α, IL-6), enhanced hepatic GSH and SOD, and attenuated liver injury. Conclusion: CUR-LPs improved glucose metabolism and insulin resistance in HFD/STZ-induced T2DM mice, which may be associated with a decrease in liver inflammation and oxidative stress. Keyworks: T2DM, curcumin, liposomes, insulin resistance, glucose metabolism, oxidative stress Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion and/or insulin action, with Type 2 diabetes mellitus (T2DM) accounting for 90–95% of diabetes patients. 1 T2DM is a metabolic disease characterized by hyperglycemia and occurs due to a variety of complex physiological and pathological processes, with insulin resistance being a hallmark characterizing. 2 Insulin resistance has a complex pathology, which is promoted by multiple factors, including inflammation and oxidation stress. 3 Inflammation and insulin resistance are closely related, and inflammatory cytokines such as TNF-α and IL-6 can inhibit insulin signaling through various mechanisms. 4 Along with inflammation, oxidative stress is also a key factor in the development of insulin resistance and T2DM. High blood glucose levels produce reactive oxygen species, which are key contributors to oxidative stress. 5 Curcumin (CUR) is a polyphenol with a relatively small molecular mass and is the most effective ingredient in turmeric, can activate multiple cell signal pathways in the body, inhibit the formation of advanced glycation end products, reduce the generation of inflammatory factors, and show antioxidant stress effects, thereby protecting islet βcells, improving glucose metabolism, and combating insulin resistance. 6 In addition, previous studies have shown that CUR can improve blood lipid levels, stimulate the antioxidant defense mechanism, and improve mitochondrial dysfunction. 7 Studies have shown that the main active ingredients of turmeric have a significant treatment effect on diabetes. 8 However, CUR has poor water solubility, is easily oxidized in vitro, has low bioavailability, and is metabolized rapidly. Therefore, CUR as a therapeutic agent has greatly limited its clinical applicat -Abstract Truncated-

Type 2 Diabetes Mellitus Decreases Systemic Exposure of Clopidogrel Active Metabolite Through Upregulation of P-glycoprotein in Rats.

Antibiotics-Induced Disruption of Gut Microbiota Increases Systemic Exposure of Clopidogrel Active Metabolite in Type 2 Diabetic Rats

Clopidogrel Resistance in a Murine Model of Diet-Induced Obesity is Mediated by the Interleukin-1 Receptor and Overcome with DT-678.

Gene Polymorphisms of Insulin Secretion Signaling Pathway Associated with Clopidogrel Resistance in Han Chinese Population.

Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db/db mice

P-glycoprotein deficiency enhances metabolic activation of and platelet response to clopidogrel through marked up-regulation of Cyp3a11 in mice: Direct evidence for the interplay between P-glycoprotein and Cyp3a

Clopidogrel-mediated P2Y 12 inhibition according to renal function in patients with diabetes mellitus and coronary artery disease

Modifying Effect of Diabetes on the Short-Term Effect of Clopidogrel in Patients with Myocardial Infarction

The mechanisms and therapeutic potential of clopidogrel in mitigating diabetic cardiomyopathy in db/db mice

Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention

The gut microbiota contributes to the modulation of intestinal CYP3A1 and P-gp in streptozotocin-induced type 1 diabetic rats

Enhanced Metabolic Activation of and Platelet Response to Clopidogrel in T Cell-Deficient Mice Through Induction of Cyp2c and Cyp3a and Inhibition of Ces1.

Long-term Effect of Clopidogrel in Patients with and Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Platelets Express Activated P2Y12 Receptor in Patients With Diabetes Mellitus.

The Pharmacokinetic Profiles of Mogrosides in T2DM Rats.

Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus

Cyp3a11‐mediated Testosterone‐6β‐hydroxylation Decreased, While UGT1a9‐mediated Propofol O‐glucuronidation Increased, in Mice with Diabetes Mellitus

Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway

Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1 α and irisin in a rat model of type 2 diabetes mellitus

Curcumin-Loaded Long-Circulation Liposomes Ameliorate Insulin Resistance in Type 2 Diabetic Mice